Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2020-04-08

FDA Approved: VALSARTAN — Supplemental Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved a supplemental application for valsartan from Macleods Pharmaceuticals Limited, indicating changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VALSARTAN (Valsartan)

Snippet

SUPPL AP for VALSARTAN (VALSARTAN)